Lise Lund Kjems - 27 Sep 2021 Form 4 Insider Report for Cyclo Therapeutics, Inc. (CYTH)

Role: Chief Medical Officer
Signature: /s/ Lise Lund Kjems
Issuer symbol: CYTH
Transactions as of: 27 Sep 2021
Net transactions value: $0
Form type: 4
Filing time: 28 Sep 2021, 09:47:01 UTC
Next filing: 02 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CYTH	Common Stock	Award	$0	+17,053		$0.000000	17,053	27 Sep 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CYTH	Stock Option (Right to buy)	Award	$0	+23,800		$0.000000	23,800	27 Sep 2021	Common Stock	23,800	$7.33	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests immediately with respect to one-quarter of the shares of common stock subject to the option, and vests with respect to the remaining shares over a four-year period in 48 equal monthly installments on the first day of each month following the date of grant.